1 / 57

Facts and Figures 2008

Facts and Figures 2008. Medicines and Health Care. The Norwegian Association of Pharmaceutical Manufacturers (LMI). 1.01 The number of marketing authorisations, active ingredients and medicines in Norway. 1.02 New and withdrawn active ingredients.

george-allison
Download Presentation

Facts and Figures 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Facts and Figures 2008 Medicines and Health Care The Norwegian Association of Pharmaceutical Manufacturers (LMI)

  2. 1.01 The number of marketing authorisations, active ingredients and medicines in Norway

  3. 1.02 New and withdrawn active ingredients

  4. 1.03 Pharmaceutical sales in Norway in the last few years, 2007-currency

  5. 1.04 Sales growth by value

  6. 1.05 Sales growth by volume (DDD)

  7. 1.06 The Norwegian pharmaceutical market by main therapeutic groups (ATC)

  8. 1.07 The top 25 Pharmaceutical companies on the Norwegian market

  9. 1.08 The top 25 medicines on the Norwegian market in terms of sales value

  10. 1.09 The top 25 active ingredients as measured by defined daily doses (DDD)

  11. 1.10 The split of sales within the distribution chain

  12. 1.11 Market share og generics (DDD)

  13. 1.12 Generics` share of the generics interchangeable market

  14. 1.13 Market share for parallel imported medicines

  15. 1.14 Market share for Wholesalers

  16. 1.15 Pharmacy chain market share

  17. 1.16 Pharmacy chain market share, excl. hospital pharmacies

  18. 1.17 Number of inhabitants per pharmacy in Europe

  19. 1.18 Pharmaceutical consumption (DDD) in the Nordic countries

  20. 1.19 Leading pharmaceutical brands on the global market

  21. 1.20 The Norwegian medicines market in relation to Europe

  22. 1.21 Leading pharmaceutical companies on the global market

  23. 2.01 Changes in prices of medicines and general inflation

  24. 2.02 Public spending on reimbursable prescription medicines

  25. 2.03 Payment for pharmaceutical consumption

  26. 2.04 Public health expenditure per inhabitant

  27. 2.05 Public spending on health care and medicines

  28. 2.06 Expenditure on medicines in the private and public sector

  29. 2.07 Daily costs for the 25 most commonly used medicines

  30. 2.08 The consumer`s medicine expenses compared to other expenses

  31. 2.09 National Insurance expenditure

  32. 2.10 Health care expenditure

  33. 2.11 Intenational price index for medicines

  34. 2.12 VAT on medicines and other goods and services in Europe

  35. 2.13 Market growth for medicines in the Nordic countries

  36. 2.14 Copayment for reimbursable medicines

  37. 2.15 Spending on medicines as share of spending on health care in the OECD

  38. 3.01 Sales on non-prescription medicines

  39. 3.02 Non-prescription medicines, share of total market value (PRP) and DDD

  40. 3.03 The top 25 non-prescription medicines an terms of sales value

  41. 3.04 Non-prescription medicines sales by selected therapy groups (ATC)

  42. 3.05 The top 10 pharmaceutical companies in the non-prescription medicines market

  43. 3.06 Non-prescription medicines, market share (PRP) in selected countries

  44. 3.07 Split by category of general sales outlets for non-prescription medicines except pharmacies

  45. 3.08 Segmentation of sales for non-prescription medicines

  46. 4.01 The top 10 veterinary medicines for aquaculture in terms of sales value

  47. 4.02 The top 10 veterinary medicines for mammels in terms of sales value

  48. 4.03 the top 5 companies within aquaculture

  49. 4.04 The top 10 companies within veterinary medicines excluding aquaculture

  50. 5.01 The investment of the pharmaceutical industry in research and development

More Related